Meta-Analysis
Copyright ©The Author(s) 2024.
World J Meta-Anal. Mar 18, 2024; 12(1): 87026
Published online Mar 18, 2024. doi: 10.13105/wjma.v12.i1.87026
Table 1 Best evidence synthesis for qualitative outcome assessment
Level of evidence
Study design
Level 1Systematic Review or multiple RCTs
Level 2One RCT or multiple comparative studies
Level 3One comparative study or non-comparative research
Level 4Expert opinion
Table 2 Study characteristics and patient geographics
Ref.
Study design
RTS or RTW
Sample size, n
Sex, F:M
Age, yr (± SD)
Patient population
Follow-up, month (± SD)
Loss to follow-up
Avci et al[25], 1998RCTRTW57 (64 enrolled) 20:37Mean = 28.9 (NR)General1.57 (11)
Bouveau et al[32], 2022RCSRTS4017:23Median = 32.9 (range: 15.6-59.9)Active populationMedian 28.8NA
Cooke et al[13], 2009RCTRTW584247:337Mean = 30 (± 10.8)General934 (6)
Eiff et al[35], 1994RCTRTW82NRRange = 16-50 (mean/median: NR)Military126 (7)
Hong et al[40], 2022PCSRTS14716:131Mean = 24.4 (± 4.9)Athletes240
Hou et al[30], 2022RCTRTS7036:34Arthroscopic: Mean = 28.3 (± 5.4); open surgery mean = 28.6 (± 4.8)Active population2410 (13)
Hupperets et al[27], 2009RCTRTS552248:274Mean = 28 (± 11.7)Athletes1214 (3)
Leanderson et al[38], 1995RCTRTW7325:48Mean = 28 (NR)General2.5NR
Lee et al[41], 2019PCSRTW18 9:9Mean = 19.3 (± 3.0)AthletesMean = 28.8 (± 4.3)0
Lee et al[42], 2020RCSRTW12535:90Mean = 32 (± 7)MilitaryMin 12, Mean 84 (NR)NR
Liu et al[43], 2022RCSRTS6420:44Mean one anchor = 30.5 (± 9.5); mean two anchor = 29.6 (± 8.0)Active population24NR
May et al [42], 2022RCSRTS5921:20aMean returners = 27.2 (± 9.3); mean non-returners = 27.1 (± 7.7)Active populationMin 2418 (30)
Melton et al[33], 2018RCSRTW12710:117Mean = 30.4 (± 6)Military10
O’Connor et al[26], 2020RCTRTW6020:40Mean = 29.5 (NR)General 110 (17%)
Punt et al[28], 2015RCTRTS9039:51Wii Fit™ mean = 34.3 (± 10.7); physical therapy mean = 34.7 (± 11.3); no therapy mean = 33.5 (± 9.5)General1.52 (2%)
Razzano et al[29], 2019RCTRTS6128:33Mean = 23 (NR)Athletes40
Rhon et al[36], 2021RCSRTS6150 8818:15684bMedian = 31.75 (range: NR)bMilitary12NA
Slatyer et al[24], 1997RCTRTW36454:310Range = 18-35 (median: NR)Military60
Takao et al[31], 2020PCSRTS9365:28Mean = 22.2 (± 12.5)Athletes12NR
Wang et al[34], 2023RCTRTS and RTW6439:22Open mean = 28.6 (± 8.1); arthroscopic mean = 27.1 (± 7.7)Generalized joint laxity patients 243 (4.7)
White et al[23], 2016PCSRTS425:37Median = 22 (range: NR)Elite athletesMedian = 44 (range: NR)0
Table 3 Risk of bias of included cohort studies and clinical trials according to the Risk of Bias in Non-randomized Studies-Interventions
Ref.
Confounding
Selection of participants
Classification of interventions
Deviation from intended interventions
Missing data
Measurements of outcomes
Selection of the reported results
Overall risk of bias
Bouveau et al[32], 2022LowLowLowLowModerateLowLowModerate
Hong et al[40], 2022LowModerateLowLowLowLowLowModerate
Lee et al[41], 2019LowModerateLowLowLowLowLowModerate
Lee et al[42], 2020ModerateLowLowLowModerateLowLowModerate
Liu et al[43], 2022ModerateModerateLowLowLowLowLowModerate
May et al[44], 2022ModerateModerateModerateLowLowLowLowModerate
Melton et al[33], 2018ModerateLow Low Low Moderate lowlowModerate
Rhon et al[36], 2021ModerateModerateLowLowLowLowLowModerate
Takao et al[31], 2020LowModerateLowLowModerateModerateLowModerate
White et al[23], 2016LowModerateLowLowLowLowLowModerate
Table 4 Quality and risk of bias of included randomized controlled clinical trial studies according to the Cochrane Risk of Bias tool
Ref.
Random sequence generation
Allocation concealment
Blinding of participants and personnel
Blinding of outcome assessment
Incomplete outcome data
Selective outcome reporting
Overall risk
Avci et al[25], 1998LowLowHighHighLowLowHigh
Cooke et al[13], 2009LowLowHighUnclearLowLowHigh
Eiff et al[35], 1994LowUnclearHighUnclearLowLowHigh
Hou et al[30], 2022LowHighHighUnclearLowLowHigh
Hupperts et al[27], 2009LowLowHighLowLowLowHigh
Leanderson et al[38], 1995LowUnclearHighUnclearLowLowHigh
O’Connor et al[26], 2010[26]LowLowHighHighLowLowHigh
Punt et al[28], 2015LowLowHighLowLowLowHigh
Razzano et al[29], 2019LowLowHighLowLowLowHigh
Wang et al[34], 2023HighHighHighUnclearLowLowHigh
Slatyer et al[24], 1997LowLowLowLowLowLowLow
Table 5 Outcomes of return to sport
Ref.
Intervention + patients (n)
Rate of RTS
Time to RTS, d (± SD)
P value
Bouveau et al[32], 2022Arthroscopic repair (19)16 (76.2)NRNS
Arthroscopic reconstruction (21)14 (67.7)NR
Hong et al[40], 2022Arthroscopic Broström with isolated injury (122)122 (100)Mean = 68.6 (range: 58-105)P = 0.004
Arthroscopic Broström with associated injury (125)125 (100)Mean = 82.8 (range: 65-132)
Hou et al[30], 2022Arthroscopic Broström (36)NRMean = 13.2 (± 2.4)P = 0.023
Open Bröstrom (34)NRMean = 18.7 (± 3.1)
Lee et al[41], 2019Open Broström early return (8)8 (100)Mean = 88.16 (± 9.12)NR
Open Broström late return (10)10 (100)Mean = 145.92 (± 39.52)
Liu et al[43], 2022Arthroscopic one anchor suture (30)23 (76.7)NRNS
Arthroscopic two anchor suture (34)26 (76.5)NR
May et al[44], 2022Modified Broström (41)22 (53.6)NRNR
Punt et al[28], 2015Wii Fit™ (30)NRMean = 27.4 (± 20.3)NS
Physical Therapy 930)NRMean = 39.7 (± 24.9)
No treatment (30)NRMean = 23.0 d (± 15.5)
Razzano et al[29], 2019Electric Therapy (32)2 month = 23 (71.9); 4 month = 27 (84.3)NR2 month, P = 0.029; 4 month, NS
No treatment (29)2 mo = 16 (55.2); 4 mo = 24 (82.7)NR
Takao et al[31], 2020A1: Unilateral arthroscopic repair (43)NRMean = 41.6 d (± 18.2)Group A vs group B, P < 0.001; group A1 vs group A2, NS; group B1 vs group B2, P = 0.001
A2: Bilateral arthroscopic repair (16)NRMean = 44.6 d (± 22.5)
B1: Arthroscopic repair + ankle stabilization + postop nonweight bearing (22)NRMean = 70.7 d (± 23.1)
B2: Arthroscopic repair + ankle stabilization + postop weight bearing (12)NRMean = 45.0 d (± 13.7)
Wang et al[34], 2023Arthroscopic Broström (30)21 (70.0)Mean = 15.1 wk (± 7.8 wk)NS
Open Broström (31)22 (71.0)Mean = 17.2 wk (± 9.3 wk)
White et al[23], 2016Modified Broström, isolated injuryNRMedian = 77 (range: 56-127)P < 0.001
Modified Broström, associated injuriesNRMedian = 105 (range: 82-178)
Table 6 Time of return to sport
Intervention type
Mean d to RTS (± SD)
Pooled mean d to RTS (± SD)
Arthroscopic surgery13.2 (± 2.4)[30]; 105.7 (± 54.6)[34] 60 (± 46)
Open surgery18.7 (± 3.1)[30]; 120.4 (± 65.1)[34] 70 (± 51)
All surgery13.2 (± 2.4)[30]; 18.7 (± 3.1)[30]; 105.7 (± 54.6)[34]; 120.4 (± 65.1)[34]65 (± 49)
Functional treatment27.4 (± 20.3)[28]; 39.7 (± 24.9)[28] 34 (± 6.2)
No treatment23 (± 15.5)[28]23 (± 16)
Table 7 Outcomes return to work
Ref.
Intervention + patients (n)
Rate of RTW, n (%)
Time to RTW in mean d (± SD)
P value
Avci et al[25], 1998Soft cast tape (31)NR2.5 (NR)P < 0.001
Scotch plus tape (26)NR6.3 (NR)
Cooke et al[13], 2009Below knee cast (142)NR7.7 (NR)NR
Aircast (149)NR9.6 (NR)
Bledsoe brace (149)NR6.9 (NR)
Tubular bandage (144)NR7.7 (NR)
Eiff et al[35], 1994Early mobilization (40)10 d = 22: (54); 3 wk = 30 (75); 6 wk = 36 (97); 3 month = 40 (100); 6 month = 40 (100)4.3 (NR)10 d, P < 0.001
Immobilized (37)10 d = 4 (13); 3 wk = 29 (79); 6 wk = 36 (96); 3 month = 37 (100); 6 month = 37 (100)4.7 (NR)
Leanderson et al[38], 1995Air-Stirrup ankle brace (39)NR5.3 (range: 0-26)P < 0.05
Compression bandage (34)NR9.1 (range: 0-21)
Lee et al[42], 2020Isolated ankle stabilization with fibular periosteum augment (99)88 (88.9)NRNS
Isolated ankle stabilization without fibular periosteum augment (26)18 (69.2)NR
Melton et al[33], 2018Modified Broström (127)93 (73.2)NRNA
O’Connor et al[29], 2020Tubigrip (18)NR5.2 (± 4.9)NS
Elastoplast (20)NR3.7 (± 3.5)
No Support (16)NR5.8 (± 4.7)
Slatyer et al[24], 1997Piroxicam (184)1732.74 (NR)P < 0.001
Placebo (180)1678.57 (NR)
Wang et al[34], 2023Arthroscopic Broström (30)NR6.8 (± 2.1)P = 0.006
Open Broström (31)NR8.1 (± 2.4)
Table 8 Time of return to work
Intervention type
Means d to RTW (± SD)
Pooled mean d to RTW (± SD)
Arthroscopic surgery6.8 (± 2.1)[34]6.8 (± 2.1)
Open surgery8.1 (± 2.4)[34]8.1 (± 2.4)
All surgery6.8 (± 2.1)[34]; 8.1 (± 2.4)[34]7.5 (± 0.7)
Functional treatment6.3 (NR)[25]; 2.5 (NR)[253]; 7.7 (NR)[13]; 9.6 (NR)[13]; 6.9 (NR)[13]; 7.7 (NR)[13]; 4.3 (NR)[35]; 4.7 (NR)[35]; 9.1 (range 0-21)[38]; 5.3 (range: 0-26)[238]; 5.2 (± 4.9)[26]; 3.7 (± 3.5)[265]; 2.74 (NR)[249]5.8 (± 2.2)
No treatment5.8 (± 4.7)[265]; 8.57 (NR)[24]7.2 (± 1.4)